Literature DB >> 19124175

Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.

Monica Garcia-Alloza1, Laura A Borrelli, Bradley T Hyman, Brian J Bacskai.   

Abstract

Senile plaques are a major pathological hallmark of Alzheimer's disease (AD). Compelling evidence suggests that senile plaques lead to structural alterations of neuronal processes and that local toxicity may be mediated by increased oxidative stress. Anti-oxidant therapy can alleviate the neuronal abnormalities in APP mice, but the time-course of this beneficial effect is unknown. We used multiphoton microscopy to assess in vivo the characteristics of antioxidant treatment on senile plaques and neurites in AD model mice (APPswe/PS1dE9). We observed that α-phenyl-N-tert-butyl nitrone (PBN), Ginkgo biloba extract (EGb 761) and Trolox had no effect on the size of existing senile plaques. However, all anti-oxidants had a straightening effect on curved neurites. This effect was detected as soon as 4 days after commencing the treatment, and was maintained after 1 month of daily treatment, with no further increase in the effect. The straightening of neurites persisted 15 days after stopping the treatment. These data indicate that neuronal plasticity is fast and still active in adult animals, and suggest that amelioration of the neuritic distortions associated with senile plaques with antioxidants is both rapid and long lasting.
Copyright © 2008 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124175      PMCID: PMC2996241          DOI: 10.1016/j.neurobiolaging.2008.11.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  62 in total

1.  Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model.

Authors:  J A Joseph; N A Denisova; G Arendash; M Gordon; D Diamond; B Shukitt-Hale; D Morgan
Journal:  Nutr Neurosci       Date:  2003-06       Impact factor: 4.994

2.  Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

Authors:  P L Le Bars; F M Velasco; J M Ferguson; E C Dessain; M Kieser; R Hoerr
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

3.  Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.

Authors:  B Urbanc; L Cruz; R Le; J Sanders; K Hsiao Ashe; K Duff; H E Stanley; M C Irizarry; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-09       Impact factor: 11.205

Review 4.  Nitrones as neuroprotectants and antiaging drugs.

Authors:  Robert A Floyd; Kenneth Hensley; Michael J Forster; Judith A Kelleher-Anderson; Paul L Wood
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

5.  Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Authors:  William E Klunk; Brian J Bacskai; Chester A Mathis; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Manik L Debnath; Daniel P Holt; Yanming Wang; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

6.  PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.

Authors:  Robert P Brendza; Cara O'Brien; Kelly Simmons; Daniel W McKeel; Kelly R Bales; Steven M Paul; John W Olney; Joshua R Sanes; David M Holtzman
Journal:  J Comp Neurol       Date:  2003-02-17       Impact factor: 3.215

7.  In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavine-S-associated alterations in neurite trajectories.

Authors:  J D D'Amore; S T Kajdasz; M E McLellan; B J Bacskai; E A Stern; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2003-02       Impact factor: 3.685

Review 8.  Ginkgo biloba for cognitive impairment and dementia.

Authors:  J Birks; E V Grimley; M Van Dongen
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761.

Authors:  Yuan Luo; Julie V Smith; Vijaykumar Paramasivam; Adam Burdick; Kenneth J Curry; Justin P Buford; Ikhlas Khan; William J Netzer; Huaxi Xu; Peter Butko
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-04       Impact factor: 11.205

10.  In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy.

Authors:  Megan E McLellan; Stephen T Kajdasz; Bradley T Hyman; Brian J Bacskai
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  20 in total

1.  Age-dependent and tissue-related glutathione redox status in a mouse model of Alzheimer's disease.

Authors:  Cheng Zhang; Cynthia Rodriguez; James Spaulding; Tak Yee Aw; June Feng
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Cerebrovascular lesions induce transient β-amyloid deposition.

Authors:  Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

3.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

Review 4.  Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Authors:  Robert A Floyd; Hugo C Castro Faria Neto; Guy A Zimmerman; Kenneth Hensley; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2013-02-16       Impact factor: 7.376

5.  Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Diana H Thyssen; Suzanne E Hickman; Joseph El Khoury; Brian J Bacskai
Journal:  Intravital       Date:  2013-04-01

6.  Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.

Authors:  M Coma; L Serenó; B Da Rocha-Souto; T C Scotton; J España; M B Sánchez; M Rodríguez; J Agulló; C Guardia-Laguarta; M Garcia-Alloza; L A Borrelli; J Clarimón; A Lleó; B J Bacskai; C A Saura; B T Hyman; T Gómez-Isla
Journal:  Neurobiol Dis       Date:  2010-02-10       Impact factor: 5.996

7.  Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.

Authors:  Marta Cortes-Canteli; Justin Paul; Erin H Norris; Robert Bronstein; Hyung Jin Ahn; Daria Zamolodchikov; Shivaprasad Bhuvanendran; Katherine M Fenz; Sidney Strickland
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

8.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30

9.  Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Mar Pacheco-Herrero; Diana Thyssen; Maria Isabel Murillo-Carretero; Esther Berrocoso; Tara L Spires-Jones; Brian J Bacskai; Monica Garcia-Alloza
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

10.  Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice.

Authors:  Carmen Infante-Garcia; Juan Jose Ramos-Rodriguez; Irene Delgado-Olmos; Carlos Gamero-Carrasco; Maria Teresa Fernandez-Ponce; Lourdes Casas; Casimiro Mantell; Monica Garcia-Alloza
Journal:  Mol Neurobiol       Date:  2016-07-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.